We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$138M
AUM Growth
-$6.49M
Cap. Flow
-$11.1M
Cap. Flow %
-8%
Top 10 Hldgs %
47.06%
Holding
111
New
11
Increased
35
Reduced
32
Closed
24

Top Buys

Rank Stock Value
1
PTEN icon
Patterson-UTI
PTEN
+$7.78M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$3.91M
3
INTC icon
Intel
INTC
+$3.72M
4
EWQ icon
iShares MSCI France ETF
EWQ
+$1.74M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$1.7M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$4.7M
2
UTEK
Ultratech Inc.
UTEK
+$4.61M
3
JCI icon
Johnson Controls International
JCI
+$2.15M
4
MPC icon
Marathon Petroleum
MPC
+$2.12M
5
AGN
Allergan plc
AGN
+$2.09M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Energy 20.47%
3 Healthcare 19.39%
4 Materials 5.38%
5 Industrials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
76
Adobe
ADBE
$99.5B
$286K 0.21%
2,200
-500
-19% -$58.7K
ITW icon
77
Illinois Tool Works
ITW
$82.6B
$265K 0.19%
2,000
-2,000
-50% -$259K
SON icon
78
Sonoco
SON
$5.57B
$265K 0.19%
5,000
-3,000
-38% -$161K
HRB icon
79
H&R Block
HRB
$5.58B
$256K 0.19%
11,000
-22,500
-67% -$503K
DBD
80
DELISTED
Diebold Nixdorf Incorporated
DBD
$255K 0.18%
8,300
-2,500
-23% -$70.6K
DAL icon
81
Delta Air Lines
DAL
$57.5B
$230K 0.17%
5,000
-5,000
-50% -$244K
HWM icon
82
Howmet Aerospace
HWM
$113B
$216K 0.16%
10,693
-7,605
-42% -$149K
AMZN icon
83
Amazon
AMZN
$2.92T
$208K 0.15%
4,700
-25,200
-84% -$1.05M
PSQ icon
84
ProShares Short QQQ
PSQ
$824M
$203K 0.15%
960
– –
HYT icon
85
BlackRock Corporate High Yield Fund
HYT
$1.36B
$148K 0.11%
13,550
+800
+6% +$8.79K
CCJ icon
86
Cameco
CCJ
$37.6B
$138K 0.1%
12,500
-17,500
-58% -$200K
ABBV icon
87
AbbVie
ABBV
$443B
– –
-30,734
Closed -$1.93M
ADNT icon
88
Adient
ADNT
$1.65B
– –
-5,225
Closed -$306K
BCO icon
89
Brink's
BCO
$4.88B
– –
-31,375
Closed -$1.29M
BIIB icon
90
Biogen
BIIB
$30B
– –
-6,800
Closed -$1.93M
CHRW icon
91
C.H. Robinson
CHRW
$17.4B
– –
-7,500
Closed -$549K
EMR icon
92
Emerson Electric
EMR
$83.9B
– –
-16,498
Closed -$920K
FLS icon
93
Flowserve
FLS
$9.71B
– –
-16,000
Closed -$769K
JCI icon
94
Johnson Controls International
JCI
$88.8B
– –
-52,262
Closed -$2.15M
MET icon
95
MetLife
MET
$61.9B
– –
-6,732
Closed -$323K
MPC icon
96
Marathon Petroleum
MPC
$92.4B
– –
-42,000
Closed -$2.12M
MTB icon
97
M&T Bank
MTB
$35.7B
– –
-3,000
Closed -$469K
PBI icon
98
Pitney Bowes
PBI
$2.37B
– –
-15,000
Closed -$228K
PTCT icon
99
PTC Therapeutics
PTCT
$5.64B
– –
-431,135
Closed -$4.7M
QID icon
100
ProShares UltraShort QQQ
QID
$282M
– –
-125
Closed -$239K
1 2 3
4
5

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Sicart Associates held 111 positions worth $138M, down 4.5% from $145M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sicart Associates withdrew a net $11.1M in Q1 2017, closing 24 positions and reducing 32 holdings. Its most notable exit was PTC Therapeutics, an estimated $4.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Sicart Associates opened a new position in iShares MSCI France ETF worth $1.81M.

  • Sicart Associates's largest Q1 2017 buy was iShares MSCI France ETF: 68,450 shares worth $1.81M.
  • Sicart Associates added most to Patterson-UTI in Q1 2017, an estimated $7.78M increase.
  • Sicart Associates's biggest Q1 2017 reduction was Weyerhaeuser, cutting an estimated $1.79M.
  • Sicart Associates fully exited PTC Therapeutics in Q1 2017, selling an estimated $4.7M.
  • Sicart Associates's ten largest holdings make up 47% of its $138M portfolio in Q1 2017.
  • Sicart Associates opened 11 new positions and closed 24 in Q1 2017.
  • Sicart Associates's portfolio value fell 4.5% quarter-over-quarter to $138M.

Based on Sicart Associates's 13F filing for Q1 2017, filed 10 Apr 2017.